USD 786.53 million
Report ID: SQMIG35G2213 | Region: Global | Published Date: February, 2024 | Pages: 165 | Tables: 122 | Figures: 79
Lymphedema Treatment Market size was valued at USD 786.53 million in 2021 and is poised to grow from USD 860.14 million in 2022 to USD 1735.36 million by 2030, growing at a CAGR of 9.5% in the forecast period (2023-2030).
Lymphedema is a disorder characterized by abnormal bodily swelling brought on by lymphocytosis due to lymphatic system dysfunction. 90% of the time, it affects the lower extremity, 10% the upper extremity, and 1% the genitalia. The infection brought on by the parasite Wuchereria bancrofti is the most frequent cause of lymphedema (filariasis). One of the most dreaded and unfortunate side effects of breast cancer treatment is lymphedema. A National Center for Biotechnology Information (NCBI) report states that 40% of women receiving treatment for breast cancer had lymphedema. The increasing incidence of breast cancer, the rising prevalence of lymphedema, the launch of several new products by major market players, and the rising demand for effective goods as a result of technical improvements are the main drivers of the lymphedema treatment market expansion.
According to the United States Department of Health and Human Services, lymphedema, which affects lymph node draining, can develop in cancer patients either at the beginning of the disease or after therapy. For instance, it has been observed that it might happen right away or up to 30 years following breast cancer therapy. In addition, 80% of patients exhibit beginning within 3 years following surgery, with the other 20% developing edema at a 1% per year pace. In addition, a sizable patient population, mostly women, experience lower-limb lymphedema following the management of gynecologic cancer, with vulvar cancer survivors having the highest frequency (37%) and ovarian cancer survivors having the lowest prevalence (7%). Additionally, two years after surgery, the overall incidence of arm lymphedema ranged from 8% to 56%. The American College of Surgeons Oncology Group (ACOSOG) Alliance Z 1071 longitudinal substudy reports that patients in breast cancer trials report a 3-year cumulative incidence of arm edema and arm heaviness. Options for cancer therapy that are very successful and cutting edge help to reduce the likelihood of lymphedema. As a result, the market's key players for cancer therapies are putting a lot of effort into introducing new products.
US Lymphedema Treatment Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 786.53 million
To get more reports on the above market click here to Buy The Report
Global lymphedema treatment market has been segmented based on end-user, product, type, route of administration, age group, affected area, and region.
Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. Based on product, the market is segmented into compression bandages, compression stockings, pneumatic compression devices, others. Based on affected area, the market is segmented into Genital, Lower Extremity, Upper Extremity and Others. Based on age group, the market is segmented into adult and geriatric. Based on route of administration, the market is segmented into Oral, Injectable and Others. Based on type, the market is segmented into primary and secondary lymphedema. Based on condition type, the market is segmented into cancer, cardiovascular diseases, inflammatory diseases, and others. Based on treatment type, the market is segmented into Compression Therapy, Surgery, Drug Therapy, Laser Therapy, and Others. Based on region, the global market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Lymphedema Treatment Market Analysis by End-User
The hospital sector is predicted to have the most revenue share in 2021 and dominate the market throughout the projection period. The significant number of patients who come directly to the hospital for Lymphedema diagnosis and treatment is driving the segment growth.
In addition, it is projected that the segment's expansion will be fueled by the increased acceptance of less invasive procedures combined with novel and advanced therapies. Additionally, the segment is anticipated to experience significant growth potential due to the rising number of hospitals providing Lymphedema treatments in emerging nations.
During the forecast period, the specialty clinics segment is expected to have the highest CAGR. The fact that Lymphedema treatment is mostly provided in specialist units or centers can be blamed for the segment's rapid expansion. Specialty clinics with a separate section for treating lymphedema perform specialized surgical therapies such as debulking and liposuction. Additionally, the expansion of specialist clinics across the globe is predicted to accelerate market expansion.
To get detailed analysis on other segments, Request For Sample Report
North America held the largest market share in 2021 due to the region's rapidly developing technological breakthroughs in the healthcare industry. Additionally, there is likely to be a tonne of potential for market expansion due to the increased awareness of IgG4-related disorders. Additionally, the market is anticipated to be led by the rising prevalence of lymphedema in nations like the U.S. and Canada as a result of rising breast cancer rates in those nations. For example, the Lymphatic Education & Research Network estimates that about 10 million Americans experience lymphedema and other lymphatic illnesses. These illnesses affect more individuals in the US than multiple sclerosis, muscular dystrophy, Parkinson's disease, and AIDS combined.
The Asia Pacific region is anticipated to have the highest market share during the forecast period. This expansion can be attributed to the rising incidence of chronic diseases, improvements in the healthcare system, and an increase in government and pharmaceutical company R&D efforts to create lymphedema treatment strategies. Faster growth in emerging economies like India and China is anticipated to benefit the expansion of the lymphedema treatment market. Due to rising disposable income, China is dominating the Asia-Pacific market.
Europe is expected to have the second-largest market share during the forecast period. The lymphedema treatment market in this region is projected to rise as a result of leading industry participants' cooperation initiatives and the development of new products. Additionally, the increased incidence of lymphedema contributes to the market expansion in the region. For instance, the NHS estimates that 200,000 people in the UK experience lymphedema each year.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Lymphedema Treatment Market Driver
Lymphedema Treatment Market Restraint
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Very few companies compete in the global lymphedema treatment market, but many of them could employ various growth tactics to keep their position in the market as a whole. To expand and surpass some of their rivals in the global lymphedema treatment market, the smaller players in the market would look for funding from private investors. In the upcoming years, lymphedema treatment market companies may use R&D as a key growth strategy. For instance, In May 2021, AIROS® Medical Inc., a medical technology manufacturer specializing in compression therapy products, announced the launch of AIROS 6 Sequential Compression Therapy devices and Arm Plus garments soon after it was granted multiple regulatory approvals by the U.S. Food and Drug Administration (FDA).
Top Players in the Global Lymphedema Treatment Market
Lymphedema Treatment Market Recent Development
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, by end-user, hospitals dominated the global lymphedema treatment market in 2021 and are anticipated to maintain their dominance throughout the forecast period. In 2021, North America dominated the global lymphedema treatment market owing to the region's rapidly developing technical breakthroughs in the healthcare industry.
|Market size value in 2021
|USD 786.53 million
|Market size value in 2030
|USD 1735.36 million
|Forecast Unit (Value)
|North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Lymphedema Treatment Market Recent Development
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Lymphedema Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Lymphedema Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Lymphedema Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Lymphedema Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.